furosemide has been researched along with baclofen in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (20.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 6 (40.00) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Shirakawa, J; Tanaka, C; Taniyama, K | 1 |
| Hanada, S; Tanaka, C; Taniyama, K | 1 |
| Graf, PD; Nadel, JA; Tamaoki, J | 1 |
| Alkon, DL; Axelrod, J; Collin, C; Dahl, D; Devane, WA; Lee, CJ | 1 |
| Alger, BE; Martin, LA; Wei, DS | 1 |
| Volkov, EM; Volkov, ME; Zefirov, AL | 1 |
| Callera, JC; Da Silva, CZ; Menani, JV | 1 |
| Andrade, CA; Andrade-Franzé, GM; Colombari, DS; De Luca, LA; De Oliveira, LB; Menani, JV | 1 |
1 review(s) available for furosemide and baclofen
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
14 other study(ies) available for furosemide and baclofen
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
gamma-Aminobutyric acid-induced modulation of acetylcholine release from the guinea pig lung.
Topics: Acetylcholine; Animals; Baclofen; Bicuculline; Calcium; Dose-Response Relationship, Drug; Female; Furosemide; gamma-Aminobutyric Acid; Guinea Pigs; Hexamethonium; Hexamethonium Compounds; In Vitro Techniques; Lung; Male; Muscimol; Tetrodotoxin | 1987 |
Autoreceptors regulate gamma-[3H]aminobutyric acid release from the guinea pig small intestine.
Topics: Animals; Baclofen; Bicuculline; Female; Furosemide; gamma-Aminobutyric Acid; Guinea Pigs; Ileum; Male; Muscimol; Myenteric Plexus; Potassium; Receptors, GABA-A; Tetrodotoxin | 1985 |
Effect of gamma-aminobutyric acid on neurally mediated contraction of guinea pig trachealis smooth muscle.
Topics: Acetylcholine; Animals; Baclofen; Furosemide; gamma-Aminobutyric Acid; Guinea Pigs; Hemicholinium 3; In Vitro Techniques; Muscimol; Muscle Contraction; Muscle, Smooth; Naloxone; Phentolamine; Propranolol; Trachea | 1987 |
Long-term synaptic transformation of hippocampal CA1 gamma-aminobutyric acid synapses and the effect of anandamide.
Topics: Animals; Arachidonic Acids; Baclofen; Calcium Channel Blockers; Chloride Channels; Endocannabinoids; Furosemide; gamma-Aminobutyric Acid; Hippocampus; In Vitro Techniques; Long-Term Potentiation; Male; Models, Neurological; Polyunsaturated Alkamides; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Snails; Synapses; Synaptic Transmission | 1995 |
Heterogeneous susceptibility of GABA(A) receptor-mediated IPSCs to depolarization-induced suppression of inhibition in rat hippocampus.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Action Potentials; Animals; Baclofen; Carbachol; Cholinergic Agents; Diuretics; Electric Stimulation; Excitatory Amino Acid Antagonists; Furosemide; GABA Agonists; GABA Antagonists; gamma-Aminobutyric Acid; Hippocampus; Interneurons; Kinetics; Male; Neural Inhibition; Norepinephrine; Organ Culture Techniques; Organophosphorus Compounds; Patch-Clamp Techniques; Potassium; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Sympathomimetics | 2001 |
Ionic selectivity of chloride ion symport in mechanisms controlling resting potential and osmotic homeostasis in earthworm somatic muscle cells.
Topics: Animals; Baclofen; Bromides; Chlorides; Furosemide; GABA Agonists; Homeostasis; Ion Transport; Membrane Potentials; Muscle Cells; Oligochaeta; Osmosis; Sodium Potassium Chloride Symporter Inhibitors | 2008 |
Natriorexigenic effect of baclofen is reduced by AT₁ receptor blockade in the lateral parabrachial nucleus.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Baclofen; Captopril; Diuretics; Drinking; Drinking Behavior; Furosemide; GABA-B Receptor Agonists; Losartan; Male; Pons; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Sodium Chloride | 2011 |
Gabaergic and opioid receptors mediate the facilitation of NaCl intake induced by α₂-adrenergic activation in the lateral parabrachial nucleus.
Topics: Animals; Antihypertensive Agents; Baclofen; Bicuculline; Captopril; Enzyme Inhibitors; Furosemide; GABA-A Receptor Antagonists; GABA-B Receptor Agonists; Imidazoles; Male; Naloxone; Narcotic Antagonists; Parabrachial Nucleus; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Receptors, GABA; Receptors, Opioid; Sodium Chloride; Sodium Potassium Chloride Symporter Inhibitors | 2015 |